Treatment for Group B Streptococcus UTI in Non-Pregnant Symptomatic Patient
Treat this symptomatic GBS urinary tract infection with ampicillin or penicillin for 7 days, and separately address the ureaplasma with doxycycline or azithromycin if clinically indicated.
GBS Treatment Approach
The presence of GBS in urine at any colony count in a symptomatic patient warrants treatment. While the provided guidelines focus primarily on perinatal GBS prevention 1, 2, the research evidence clearly establishes GBS as a significant urinary pathogen in non-pregnant adults 3, 4.
First-Line Antibiotic Selection
Ampicillin or penicillin G remains the treatment of choice based on:
- Universal susceptibility: All GBS isolates maintain 100% susceptibility to penicillin and ampicillin 5, 4, 6
- The perinatal guidelines consistently recommend penicillin/ampicillin as first-line agents 2
- Recent studies confirm continued excellent activity 7
Recommended regimens:
- Ampicillin 500 mg orally four times daily for 7 days, or
- Amoxicillin 500 mg orally three times daily for 7 days
Duration Considerations
While standard UTI treatment is often 3-5 days, 7 days is more appropriate for GBS UTI because:
- GBS can colonize multiple sites (urethra, vagina, gastrointestinal tract) serving as reservoirs 5, 8
- The low CFU count (10,000-25,000) doesn't diminish clinical significance when symptomatic 3
- Longer courses help eradicate colonization and prevent recurrence 5
Alternative Agents for Penicillin Allergy
If penicillin-allergic without high-risk features (no history of anaphylaxis, angioedema, respiratory distress):
- Cefazolin or other first-generation cephalosporins 2
If penicillin-allergic with high-risk features:
- Vancomycin 1 g IV every 12 hours (requires hospitalization) 2
- Clindamycin 300 mg orally three times daily - but note resistance rates of 5-10% 6, 7
Important caveat: Trimethoprim-sulfamethoxazole, while used successfully in one case report 9, shows variable susceptibility and is not recommended as first-line given universal penicillin susceptibility.
Resistance Patterns to Avoid
Do not use:
- Gentamicin or aminoglycosides - GBS shows intrinsic resistance 3
- Quinolones - resistance rates up to 22.5% in recent studies 6
- Erythromycin - resistance rates 28-72% 6, 7
- Tetracycline - resistance rates up to 81.5% 7
Ureaplasma Co-Infection Management
The positive ureaplasma requires separate consideration as a distinct pathogen:
If symptomatic urethritis/dysuria persists after GBS treatment:
- Doxycycline 100 mg orally twice daily for 7 days, or
- Azithromycin 1 g orally as single dose
Key distinction: Ureaplasma is not susceptible to beta-lactams, so the ampicillin/penicillin treating GBS will not address ureaplasma.
Clinical Pitfalls to Avoid
Don't dismiss low CFU counts - The 10,000-25,000 CFU range is clinically significant when symptomatic, particularly for GBS which may represent early infection or mixed colonization 3, 8
Screen for underlying conditions - GBS UTI in non-pregnant adults signals need for evaluation of:
Consider reservoir sites - In women, vaginal colonization may serve as a reservoir requiring local treatment with chlorhexidine vaginal lavages if recurrence occurs 5, 8
Don't use Congo red agar for biofilm testing - This method is unreliable for GBS due to binding with capsular sialic acid 6